These findings not only reveal the potential molecular mechanisms underlying SQYSF’s effects in treating DKD but also suggest that targeting YTHDF1 may provide a novel approach for the prevention and treatment of DKD. Here, YTHDF1 is linked to diabetic kidney disease.